Digestive cancers are rapidly emerging as one of the leading causes of cancer-related mortality worldwide, with colorectal and pancreatic cancers being especially insidious due to their silent progression. In India alone, digestive tract cancers account for nearly 20% of all cancer cases, yet awareness and early detection remain alarmingly low. Against this backdrop, Dr. Vipulroy Rathod, a distinguished Gastroenterologist in Mumbai, India, is redefining cancer diagnostics through the use of cutting-edge endoscopic techniques.
As a globally respected Endoscopist in Mumbai, India, Dr. Rathod has performed over 25000 endoscopic ultrasound (EUS) procedures and over 80000 various diagnostic and advanced therapeutic endoscopic procedures and pioneered advanced diagnostic protocols that have saved countless lives. His work emphasizes early detection and minimally invasive intervention as the most effective tools in the fight against gastrointestinal cancers. “The digestive tract is a complex but accessible window into systemic health. Ignoring symptoms like acid reflux, abdominal discomfort, or irregular bowel habits may delay the diagnosis of serious conditions, including malignancies,” says Dr. Rathod.
With colorectal cancer now ranked as the third most common cancer globally, early screening methods such as high-definition and magnification colonoscopy with narrow band imaging (NBI)and EUS-guided biopsies for small nodes not seen on PET CT /MRI has impacted the treatment design. These technologies allow for the detection of polyps, tumors, and lesions before symptoms become severe. “Our facility combines precision imaging with therapeutic capabilities, enabling us to not just detect but treat early-stage cancers during the same session, significantly improving patient outcomes,” explains Dr. Rathod.
Operating from Fortis Hospital, Mulund as the Director of Gastroenterology Department, Dr. Rathod and his multidisciplinary team offer a wide range of diagnostic and therapeutic procedures, including gastroscopy, colonoscopy, pancreatic and biliary endoscopy, and liver disease management. The integration of advanced modalities like linear and radial EUS, elastography, and contrast-enhanced imaging provides unparalleled accuracy in evaluating conditions like pancreatic cysts, esophageal cancer, hepatitis, and inflammatory bowel disease (IBD).
In one recent high-impact case, a 52-year-old male reported vague symptoms—bloating and fatigue—that were initially attributed to lifestyle stress. However, Dr. Rathod’s thorough endoscopic evaluation uncovered a 1.2 cm pancreatic mass, which was confirmed as early-stage cancer. Immediate surgical intervention was possible due to timely detection. Today, the patient is cancer-free and living a healthy life, underscoring how proactive screening can change the trajectory of a disease once deemed incurable. Endoscopic Ultrasound also helps in identifying the cause of Acute, Recurrent Acute and Chronic Pancreatitis and that in turn helps to offer selected patients an Endoscopic treatment option with ERCP.
Dr. Rathod’s approach to care is built on personalization, prevention, and precision. Each patient undergoes a risk-based assessment followed by tailored interventions, including dietary modifications, pharmacological therapy, and endoscopic treatment if necessary. His work is further supported by a global reputation, having trained over 450 gastroenterologists from 35+ countries and conducted 2000 national and international lectures and live surgical demonstrations.
In India, where over 200 million people are estimated to suffer from gastrointestinal disorders, public education and access to specialized care remain critical. Many conditions—such as IBS, GERD, peptic ulcers, and cirrhosis—are chronic and poorly managed due to late diagnosis. “By investing in high-quality, real-time diagnostics, we not only identify cancer but also improve the management of chronic GI diseases that often precede it,” says Dr. Rathod.
His affiliations with leading organizations like the Fellow of American Society of Gastrointestinal Endoscopy (FASGE), the Fellow of Indian Association of Gastrointestinal EndoSurgeons(EFIAGES), and the Past President of Society of Gastrointestinal Endoscopy of India (SGEI) reflect his commitment to aligning Indian gastroenterology with international clinical standards.
Education and patient empowerment are at the core of his mission. Through platforms like the Dr. Rathod Medical Foundation and collaborations with academic institutions such as Yale University, he continues to drive innovation and mentorship in gastrointestinal science.
For individuals experiencing recurring digestive discomfort, irritable bowel symptoms, or unexplained weight loss, early consultation with a specialist can be life-saving. Dr. Rathod’s clinic offers prompt evaluation, second opinions, and advanced diagnostics for both local and international patients.
Under the expert guidance of Dr. Vipulroy Rathod, patients are not just treated—they are educated, empowered, and given hope through evidence-based, technologically advanced care. His Mumbai-based practice that spans three decades stands as one of India’s most trusted destinations for gastrointestinal wellness and cancer prevention.
📍Dr. Vipulroy Rathod
Gastroenterology Institute, 5th Floor, Fortis Hospital, Goregaon-Mulund Link Rd, Nahur West, Industrial Area, Bhandup West, Mumbai, Maharashtra 400078
📞 +91-9820091763
📧 [email protected]
